Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Shitara

Showing results (61-70 of 375) with videos related to

Pageof 38
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 13, 2006
[A case of advanced gastric cancer with long-term survival treated by chemotherapy and surgical cytoreduction]Atsushi Ishiguro, Masaki Munakata, Kohei Shitara, et al.
Oncology|August 21, 2008
Prolongation of survival and improvement in performance status following palliative chemotherapy in gastrointestinal cancer patients with a poor performance statusKohei Shitara, Masaki Munakata, Masaharu Kasai, et al.
Japanese Journal of Clinical Oncology|November 26, 2020
Current status of immunotherapy for advanced gastric cancerAkihito Kawazoe, Kohei Shitara, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology|June 15, 2021
Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in JapanYusuke Takushima, Ataru Igarashi, Hiroshi Yoshihara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 15, 2005
[Recent progress of chemotherapy for colorectal cancer]Atsushi Ishiguro, Kohei Shitara, Masaki Munakata, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2013
Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapyKohei Shitara, Keitaro Matsuo, Kei Muro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 6, 2013
Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancerKohei Shitara, Keitaro Matsuo, Kei Muro, et al.
Clinical and Translational Medicine|June 15, 2024
Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumoursMasuko Katoh, Izuma Nakayama, Zev A Wainberg, et al.
Nature Reviews. Clinical Oncology|April 1, 2021
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigmYoshiaki Nakamura, Akihito Kawazoe, Florian Lordick, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 17, 2021
Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancerKohei Shitara, Eishi Baba, Kazumasa Fujitani, et al.
Pageof 38

Showing results (61-70 of 375) with videos related to

Sort By:
Pageof 38
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 13, 2006
[A case of advanced gastric cancer with long-term survival treated by chemotherapy and surgical cytoreduction]Atsushi Ishiguro, Masaki Munakata, Kohei Shitara, et al.
Oncology|August 21, 2008
Prolongation of survival and improvement in performance status following palliative chemotherapy in gastrointestinal cancer patients with a poor performance statusKohei Shitara, Masaki Munakata, Masaharu Kasai, et al.
Japanese Journal of Clinical Oncology|November 26, 2020
Current status of immunotherapy for advanced gastric cancerAkihito Kawazoe, Kohei Shitara, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology|June 15, 2021
Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in JapanYusuke Takushima, Ataru Igarashi, Hiroshi Yoshihara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 15, 2005
[Recent progress of chemotherapy for colorectal cancer]Atsushi Ishiguro, Kohei Shitara, Masaki Munakata, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2013
Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapyKohei Shitara, Keitaro Matsuo, Kei Muro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 6, 2013
Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancerKohei Shitara, Keitaro Matsuo, Kei Muro, et al.
Clinical and Translational Medicine|June 15, 2024
Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumoursMasuko Katoh, Izuma Nakayama, Zev A Wainberg, et al.
Nature Reviews. Clinical Oncology|April 1, 2021
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigmYoshiaki Nakamura, Akihito Kawazoe, Florian Lordick, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 17, 2021
Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancerKohei Shitara, Eishi Baba, Kazumasa Fujitani, et al.
Pageof 38